Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Overview

High-performance neurostimulator

The lntellis™ with AdaptiveStim™ rechargeable neurostimulator is powered by proprietary Overdrive™ battery technology. It is designed to overcome limitations with other SCS systems and is optimized for the increased energy demands of High Dose (HD) therapy.

  • Smallest fully implantable spinal cord neurostimulator
  • <1 hour recharge — empty to full (approximate time)1
  • Improved battery performance with minimal capacity fade (<5%)1
  • Designed for patient comfort and more flexible placement during the implant
  • AdaptiveStim™ technology automatically adjusts the therapy as your patient moves, delivering a personalized treatment based on seven unique body positions.
  • Snapshot™ reporting, powered by AdaptiveStim™ technology, allows physicians to objectively monitor a patient's progress.
The Intellis product family for spinal cord stimulation

Not all batteries are created equal

9-year Overdrive™ battery data1

Medtronic is the only SCS manufacturer to offer this proprietary, nontraditional lithium ion battery chemistry.
 

Overdrive™ Battery Technology

  • Faster recharge*
  • Minimal fade*
  • Overdischarge protection


What could your patients do with more time?


~1 hour recharge

from empty to full

 


up to
3x faster

than traditional lithium ion batteries*

 


Patient can recharge

a completely discharged device

 


more than
95%1

battery capacity
at 9 years1, independent of therapy parameters or recharge preferences

 

Choose innovative battery technology

Improvements made to benefit your patients' needs and comfort


Implant depth
of up to
3 cm

provides versatility and patient comfort


Decreased
revisions
 

due to flipped batteries or over-discharged batteries

 


Meets the demands of current and future workflows

including optimization for increased energy demands of HD therapies

Unrivaled battery chemistry performance

Our Overdrive™ battery technology has a proprietary chemistry compared with SCS competitor batteries that are based on conventional Li ion chemistry. Our design allows for rapid recharge with minimal impact to the battery capacity at 9 years of use even with full discharge.

Under daily, empty-to-full charge and discharge testing:

  • Medtronic’s Intellis™ Overdrive™ battery technology maintained 95% of the original capacity at 9 years and 3,200 cycles.1,2
  • The tested Competitor X spinal cord stimulators lost 30% of the capacity after only 3 years and 1,000 cycles.1,2
  • The Intellis™ devices can be recharged in ~1 hour from empty to full vs. up to 4 hours with the tested Competitor X devices.

Thus, patients will have a more consistent recharge interval and faster recharge experience, even under the most aggressive stimulation conditions.

Overdrive Intellis
Manufacturer X

Compatible products and features

Wireless External Neurostimulator

  • Wireless, sterile single-use external neurostimulator simplifies testing during trial and implant
  • Designed for patient comfort and convenience
Model Number 97725
Weight 71g (2.5oz)
Length 79mm (3.1in)
Width 74mm (2.9in)
Battery Type Non-rechargeable
Thickness 20mm (0.8in)
Front view of the Intellis wireless external neurostimulator

Clinician Programmer

 
  • Secure, wireless programming outside the sterile field
  • Tailored programming workflows
  • Electronic transfer of a variety of reports
  • Bluetooth® communication§
  • Requires the use of the Intellis™ clinician programmer app and communicator device
Clinician Programmer

Combined Patient Programmer and Recharger

 
 
 
  • Recharge from fully depleted battery
  • Easy-to-adjust therapy
  • Easy-to-read interface
  • Large, pliable recharge antenna designed for patient comfort
Combined Patient Programmer and Recharger

Compatible
products

  • 1x8 Vectris™ and Vectris™ SureScan™ MRI percutaneous leads and INJEX™ anchoring system models 97791 and 97792
  • 16-electrode Specify™ SureScan™ MRI surgical leads

Intellis™ with
AdaptiveStim™ technology

Model 97715
Channels 2
Volume 13.9cc
Height 57.1mm (2.2in)
Width 47.2mm (1.9in)

DTM™ SCS therapy

DTM™ SCS therapy is a proprietary therapy inspired by science and rooted in pre-clinical research, and adapted to provide superior clinical outcomes.

The DTM™ SCS 12-month RCT proved sustained superiority compared to conventional stimulation.3

  • DTM™ SCS has an 84% back pain responder rate at 12-months.
  • DTM™ SCS has a 69% profound back pain response rate (≥80% pain relief) at 12 months.
     

Unmatched full-body MRI access

  • SureScan™ MRI technology allows MRI scans anywhere on the body enabling diagnostic care.
  • Provide patients the same access as non-implanted patients — now and in the future.
  • Shielded leads and proprietary device safeguards help patients safely get an MRI.
  • Access matters — 98% of patients are expected to need at least 1 MRI within 10 years of implant.4

Manuals and technical guides

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library(opens new window). Search by the product name (Intellis™) or model number (97715). 


 

Read about DTM™ SCS

Click to learn more about DTM™ SCS, a proprietary waveform supported by pre-clinical research and clinical research delivering Superior Pain Relief. Proven.1

Learn more (opens new window)

Visit Medtronic Academy

and access detailed product information, including spec sheets, videos, and presentations.

Visit Medtronic Academy (opens new window)
*

Compared to traditional lithium ion batteries

Descriptive comparison, including studies with similar design (RCT; randomization >100 subjects; comparing 2 SCS therapies; with at least 12-months follow up) and patient populations (inclusion/exclusion criteria; baseline demographics) with back pain responder rates reported. This is not based on a statistical analysis of outcomes between studies.

MR Safety Triangle Under specific conditions. Refer to product labeling for full list of conditions. Patients with non-Medtronic leads and an EMBSNV20 adaptor extension are not eligible for an MRI.

§

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.™

1

R131649 RS2 Lithium-Ion Overdrive™ Rechargeable Battery DVT Report

2

Chao Hu, et. al. Remaining useful life assessment of lithium-ion batteries in implantable medical devices. Journal of Power Sources.(opens new window) January 31, 2018, Volume 375, pgs118-130.

3

Fishman M, Cordner H, Justiz R, et al. 12-Month Results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021; 00: 1–12. doi: 10.1111/papr.13066.

4

Desai MJ, Hargens LM, Breitenfeldt MD, et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine. 2015;40(9):E531–537.